JOHNSON FRANKLIN P JR 4
4 · AMGEN INC · Filed Aug 6, 2004
Insider Transaction Report
Form 4
AMGEN INCAMGN
JOHNSON FRANKLIN P JR
Director
Transactions
- Sale
Common Stock
2004-08-05$55.97/sh−250$13,993→ 684,400 total(indirect: By Partnership) - Sale
Common Stock
2004-08-05$56.00/sh−2,150$120,400→ 684,650 total(indirect: By Partnership) - Sale
Common Stock
2004-08-06$54.60/sh−5,000$273,000→ 679,400 total(indirect: By Partnership) - Sale
Common Stock
2004-08-05$56.23/sh−10,000$562,300→ 686,800 total(indirect: By Partnership) - Sale
Common Stock
2004-08-06$54.52/sh−10,000$545,150→ 669,400 total(indirect: By Partnership) - Sale
Common Stock
2004-08-06$54.50/sh−20,000$1,090,034→ 639,400 total(indirect: By Partnership)
Footnotes (1)
- [F1](FPJ 08.06.04) Does not include (i) 975,322 shares held as direct ownership by the reporting person, (ii) 4 units contractual contingent payment rights held as indirect ownership by Asset Management Partners (the "Partnership") arising from the purchase by Amgen Inc. of two Class A interests of Amgen Clinical Partners, L.P., and (iii) 824,888 shares held as indirect ownership by the spouse of the reporting person. The reporting person disclaims beneficial ownership of the securities held by the Partnership and his spouse and this report shall not be deemed an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 of the Securities Exchange Act of 1934.